We use non-essential cookies (including anonymous analytics) to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential for our platform to work and help us to provide you with the best experience possible. You can accept or reject our non-essential cookies and change your mind at any time. To learn more, please read our cookies policy.

Update cookie preferences

All about PARP inhibitors with Jo Stanford and Dr Jon Krell

20 Jan 2021

Tune into this conversation with Consultant Medical Oncologist at Imperial College London, Dr. Jon Krell, and our former Cancer Prevention Officer Jo Stanford. 

The pair discuss targeted cancer drug PARP inhibitors sharing how they work, their benefits, and who might be eligible to take them.